#CryptoMarket4T

The company operates two main platforms: ALT5 Pay, a cryptocurrency payment gateway for merchants, and ALT5 Prime, an over-the-counter trading platform for digital assets. ALT5 Pay enables merchants to accept cryptocurrency payments with options to convert to traditional currencies or receive payments in digital assets.

ALT5 Sigma is also advancing its business division in biotechnology, which will continue under the name Alyea Therapeutics Corporation. The biotechnology division focuses on developing non-addictive pain relief medications, including JAN123, which has received orphan drug designation from the U.S. Food and Drug Administration for the treatment of complex regional pain syndrome.